Results for
"[search-keyword]"
Sponsor content
412 result(s) found, displaying 231 to 240
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Prescription medicine registrationActive ingredients: fluticasone furoate, umeclidinium bromide, vilanterol trifenatate.
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Cancellation by sponsorRequested by GlaxoSmithKline Australia Pty Ltd
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Ambrisentan
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INCRUSE ELLIPTA umeclidinium (as bromide) 62.5 microgram powder for inhalation.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ANORO ELLIPTA 62.5/25 umeclidinium (as bromide)/vilanterol (as trifenatate) 62.5 microgram/25 microgram powder for inhalation.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AIRZATE ACCUHALER 100/50 fluticasone propionate 100 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AIRZATE ACCUHALER 250/50 fluticasone propionate 250 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack.